Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Significant Drop in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the recipient of a significant decline in short interest during the month of May. As of May 29th, there was short interest totaling 1,278,919 shares, a decline of 37.0% from the May 14th total of 2,031,410 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Genomma Lab Internacional Price Performance

OTCMKTS GNMLF opened at $1.08 on Monday. The firm’s fifty day moving average price is $1.06 and its two-hundred day moving average price is $1.03. Genomma Lab Internacional has a fifty-two week low of $0.91 and a fifty-two week high of $1.27.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.